Webinar on Orthovoltage X-rays Exhibit Increased
Interactive Webcast: 26 July 2022, Tuesday at 11:00 EDT (US), 17:00 CEST (Europe)
Amidst concerns of radiological terrorism, there are institutional initiatives to replace radionuclide sources with lower energy X-ray sources. As researchers transition, questions remain regarding whether the biological effects of gamma-rays may be recapitulated with orthovoltage X-rays because different energies may induce divergent biological effects. In the recent study, “Orthovoltage X-rays Exhibit Increased Efficacy Compared with Gamma-rays in Preclinical Irradiation,” researchers found that a dose reduction is necessary for X-rays to achieve comparable biological effects.
Join Xstrahl and Dr. Chandan Guha, Ph.D., Vice Chairman and Professor of Radiation Oncology, Albert Einstein College of Medicine, as he reviews the dichotomy between the physical dose and biological effect and explains how hematopoietic and intestinal injury increases with decreasing energy. Dr. Guha will also be available for Q&A following the presentation.
Click here to register now!
- Monitor autoantibody development in COVID-19 patient sera.
- Identify autoantibody responses after COVID-19 infection
- Investigate autoantibody responses before and after COVID-19 vaccination.
- Correlate IgG or IgA autoantibodies with disease progression.
- Analyze autoantibody responses in animal models on the epitope level.